Literature DB >> 20458183

Impaired autophagosomes and lysosomes in neuronopathic Gaucher disease.

Ying Sun1, Gregory A Grabowski.   

Abstract

Gaucher disease is an inherited autosomal recessive disease caused by mutations of acid β-glucosidase, a lysosomal hydrolase specific for degradation of glucosylceramide and glucosylsphingosine in the glycosphingolipid metabolic pathway. Clinically, Gaucher disease is classified into three types: type 1 is a visceral disease, whereas types 2 and 3 are acute and chronic neuronopathic variants, respectively. In types 2 and 3, the CNS pathology displays neuronal inclusions and neuron death. The underlying mechanism(s) by which the glycosphingolipid storage leads to this pathology is not fully understood. A mouse model whose phenotype mimicked that of the human neuronopathic variants was generated in our lab. In the brain of this model, abnormal autophagosomes and lysosomes implicate autophagy in the neuronal degeneration of Gaucher disease.

Entities:  

Mesh:

Year:  2010        PMID: 20458183     DOI: 10.4161/auto.6.5.12047

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  22 in total

Review 1.  The pathophysiology of GD - current understanding and rationale for existing and emerging therapeutic approaches.

Authors:  Derralynn A Hughes; Gregory M Pastores
Journal:  Wien Med Wochenschr       Date:  2010-12

Review 2.  Exploring the link between glucocerebrosidase mutations and parkinsonism.

Authors:  Wendy Westbroek; Ann Marie Gustafson; Ellen Sidransky
Journal:  Trends Mol Med       Date:  2011-07-01       Impact factor: 11.951

3.  A non-BRICHOS SFTPC mutant (SP-CI73T) linked to interstitial lung disease promotes a late block in macroautophagy disrupting cellular proteostasis and mitophagy.

Authors:  Arie Hawkins; Susan H Guttentag; Robin Deterding; William K Funkhouser; Jennifer L Goralski; Shampa Chatterjee; Surafel Mulugeta; Michael F Beers
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-10-24       Impact factor: 5.464

Review 4.  iPS cells in the study of PD molecular pathogenesis.

Authors:  Melanie M Cobb; Abinaya Ravisankar; Gaia Skibinski; Steven Finkbeiner
Journal:  Cell Tissue Res       Date:  2017-12-12       Impact factor: 5.249

5.  The incidence of Parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher Registry.

Authors:  Barry Rosenbloom; Manisha Balwani; Jeff M Bronstein; Edwin Kolodny; Swati Sathe; Andrea R Gwosdow; John S Taylor; J Alexander Cole; Ari Zimran; Neal J Weinreb
Journal:  Blood Cells Mol Dis       Date:  2010-11-10       Impact factor: 3.039

Review 6.  The link between the GBA gene and parkinsonism.

Authors:  Ellen Sidransky; Grisel Lopez
Journal:  Lancet Neurol       Date:  2012-11       Impact factor: 44.182

7.  Induced pluripotent stem cell model recapitulates pathologic hallmarks of Gaucher disease.

Authors:  Leelamma M Panicker; Diana Miller; Tea Soon Park; Brijesh Patel; Judi L Azevedo; Ola Awad; M Athar Masood; Timothy D Veenstra; Ehud Goldin; Barbara K Stubblefield; Nahid Tayebi; Swamy K Polumuri; Stefanie N Vogel; Ellen Sidransky; Elias T Zambidis; Ricardo A Feldman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-15       Impact factor: 11.205

8.  Modulating ryanodine receptors with dantrolene attenuates neuronopathic phenotype in Gaucher disease mice.

Authors:  Benjamin Liou; Yanyan Peng; Ronghua Li; Venette Inskeep; Wujuan Zhang; Brian Quinn; Nupur Dasgupta; Rachel Blackwood; Kenneth D R Setchell; Sheila Fleming; Gregory A Grabowski; John Marshall; Ying Sun
Journal:  Hum Mol Genet       Date:  2016-12-01       Impact factor: 6.150

Review 9.  Gaucher disease: insights from a rare Mendelian disorder.

Authors:  Ellen Sidransky
Journal:  Discov Med       Date:  2012-10       Impact factor: 2.970

10.  Is Parkinson's disease a lysosomal disorder?

Authors:  Andrés D Klein; Joseph R Mazzulli
Journal:  Brain       Date:  2018-08-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.